PS
ORIC icon

Peter Svennilson’s Oric Pharmaceuticals ORIC Stock Holding History

Peter Svennilson’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$119M Hold
4,768,181
– – 9.73% 6
2020
Q2 		$161M Buy
+4,768,181
New +$152M 13.45% 5

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Peter Svennilson's ORIC Position: Q3 2020 in Review

Peter Svennilson held its Oric Pharmaceuticals (ORIC) position steady in Q3 2020 at 4,768,181 shares worth $119M. The position accounts for 9.73% of the portfolio, ranked #6.

Peter Svennilson first reported a position in ORIC in Q2 2020 and has held it in 2 quarters since. The position peaked at $161M in Q2 2020. 54 funds tracked by Wall St. Rank hold ORIC as of Q3 2020.

  • Peter Svennilson held 4,768,181 shares of Oric Pharmaceuticals worth $119M as of Q3 2020.
  • Peter Svennilson left its Oric Pharmaceuticals share count unchanged in Q3 2020.
  • Oric Pharmaceuticals made up 9.73% of Peter Svennilson's portfolio in Q3 2020, its #6 holding.
  • Peter Svennilson first reported a position in Oric Pharmaceuticals in Q2 2020 and has held it in 2 quarters since.
  • Peter Svennilson's Oric Pharmaceuticals position peaked at $161M in Q2 2020.
  • 54 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2020.

Based on Peter Svennilson's 13F filing for Q3 2020, filed 4 Nov 2020.